Published in Clin Microbiol Rev on January 01, 2001
The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev (2009) 3.30
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol (2004) 2.44
Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol (2012) 2.10
Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol (2007) 1.93
Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog (2008) 1.92
Primate-to-human retroviral transmission in Asia. Emerg Infect Dis (2005) 1.87
Retroviral superinfection resistance. Retrovirology (2005) 1.82
Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol (2004) 1.44
Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog (2011) 1.39
Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg Infect Dis (2007) 1.35
Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. J Virol (2007) 1.30
Interspecies transmission of simian foamy virus in a natural predator-prey system. J Virol (2008) 1.25
An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog (2012) 1.24
Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol (2006) 1.23
Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein. Proc Natl Acad Sci U S A (2002) 1.19
Restriction of foamy viruses by primate Trim5alpha. J Virol (2008) 1.19
Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology (2006) 1.14
An endogenous foamy virus in the aye-aye (Daubentonia madagascariensis). J Virol (2012) 1.05
Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? Trends Immunol (2008) 1.04
Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo. Retrovirology (2012) 1.03
Protease-dependent uncoating of a complex retrovirus. J Virol (2005) 1.00
Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus. J Virol (2014) 1.00
Cell-type-specific regulation of the two foamy virus promoters. J Virol (2001) 1.00
Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. J Virol (2002) 1.00
Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells. Blood (2008) 0.99
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Genet Vaccines Ther (2004) 0.97
Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins. J Virol (2010) 0.97
Zoonotic simian foamy virus in Bangladesh reflects diverse patterns of transmission and co-infection. Emerg Microbes Infect (2013) 0.95
Intra- and intercellular trafficking of the foamy virus auxiliary bet protein. J Virol (2002) 0.93
Discovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolution. Retrovirology (2014) 0.91
Viral latency in blood and saliva of simian foamy virus-infected humans. PLoS One (2013) 0.91
The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra. J Virol (2004) 0.90
Foamy virus envelope protein is a substrate for signal peptide peptidase-like 3 (SPPL3). J Biol Chem (2012) 0.90
A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid. PLoS Pathog (2013) 0.90
Two distinct variants of simian foamy virus in naturally infected mandrills (Mandrillus sphinx) and cross-species transmission to humans. Retrovirology (2010) 0.89
Evolution of foamy viruses: the most ancient of all retroviruses. Viruses (2013) 0.89
Foamy virus vectors for gene transfer. Expert Opin Biol Ther (2009) 0.88
Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J Virol (2002) 0.87
Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission. Viruses (2013) 0.87
Innate sensing of foamy viruses by human hematopoietic cells. J Virol (2011) 0.87
Genetic characterization of simian foamy viruses infecting humans. J Virol (2012) 0.86
Emerging viruses in the Felidae: shifting paradigms. Viruses (2012) 0.85
The foamy virus Gag proteins: what makes them different? Viruses (2013) 0.85
New World simian foamy virus infections in vivo and in vitro. J Virol (2013) 0.84
Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep. J Virol (2013) 0.83
Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from Macaca cyclopis. J Virol (2013) 0.83
Studies of retroviral infection in humanized mice. Virology (2015) 0.83
Endogenous viral sequences from the Cape golden mole (Chrysochloris asiatica) reveal the presence of foamy viruses in all major placental mammal clades. PLoS One (2014) 0.82
Complete genome sequences of two novel European clade bovine foamy viruses from Germany and Poland. J Virol (2012) 0.82
Foamy virus assembly with emphasis on pol encapsidation. Viruses (2013) 0.82
Lentivirus restriction by diverse primate APOBEC3A proteins. Virology (2013) 0.81
Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma. Br J Cancer (2004) 0.80
Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats. J Virol (2003) 0.80
In vivo cellular tropism of gorilla simian foamy virus in blood of infected humans. J Virol (2014) 0.80
Simian foamy virus in non-human primates and cross-species transmission to humans in Gabon: an emerging zoonotic disease in central Africa? Viruses (2013) 0.80
Wide distribution and ancient evolutionary history of simian foamy viruses in New World primates. Retrovirology (2015) 0.80
Basic residues in the foamy virus Gag protein. J Virol (2011) 0.79
Foamy virus in the tree shrew Tupaia belangeri is highly related to simian foamy virus in Macaca mulatta. AIDS Res Hum Retroviruses (2013) 0.78
Horizontal acquisition and a broad biodistribution typify simian foamy virus infection in a cohort of Macaca fascicularis. Virol J (2013) 0.78
Drosophila errantiviruses. Mob Genet Elements (2012) 0.77
Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid. PLoS Pathog (2016) 0.76
Evaluation and prediction of the HIV-1 central polypurine tract influence on foamy viral vectors to transduce dividing and growth-arrested cells. ScientificWorldJournal (2014) 0.75
Foamy-like endogenous retroviruses are extensive and abundant in teleosts. Virus Evol (2016) 0.75
Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication. Open AIDS J (2015) 0.75
Complete Genome Sequence of a Naturally Occurring Simian Foamy Virus Isolate from Rhesus Macaque (SFVmmu_K3T). Genome Announc (2017) 0.75
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med (1954) 9.02
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Foamy viruses are unconventional retroviruses. J Virol (1999) 2.71
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology (1991) 2.70
The foamy viruses. Bacteriol Rev (1975) 2.53
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Foamy virus capsids require the cognate envelope protein for particle export. J Virol (1999) 2.30
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A (1993) 2.30
The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A (1991) 2.23
Foamy virus particle formation. J Virol (1998) 2.22
The emergence of simian/human immunodeficiency viruses. AIDS Res Hum Retroviruses (1992) 1.94
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology (1995) 1.93
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
Isolation, immunodiffusion, immunofluorescence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle. Cancer Res (1969) 1.92
A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J Virol (1997) 1.85
Evidence that the human foamy virus genome is DNA. J Virol (1999) 1.85
The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol (1998) 1.82
Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology (1995) 1.80
Infectious DNA of the human spumaretrovirus. Nucleic Acids Res (1990) 1.67
Foamy retroviruses. A virus in search of a disease. Nature (1988) 1.64
Latent viruses in chimpanzees with experimental kuru. Nature (1967) 1.64
Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol (1995) 1.62
Identification of an ER retrieval signal in a retroviral glycoprotein. Cell (1995) 1.60
Molecular cloning of the genome of human spumaretrovirus. Gene (1987) 1.52
Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med (1955) 1.51
Simian foamy virus isolated from an accidentally infected human individual. J Virol (1997) 1.51
Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology (1999) 1.48
Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science (1991) 1.46
Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol (1998) 1.46
A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology (1995) 1.37
COMPARISON OF SIMIAN FOAMY VIRUS STRAINS INCLUDING A NEW SEROLOGICAL TYPE. Nature (1964) 1.37
Identification of the simian foamy virus transcriptional transactivator gene (taf). J Virol (1991) 1.36
The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J Virol (1994) 1.34
Characterization of new simian foamy viruses from African nonhuman primates. Virology (1997) 1.33
Isolation and characterization of an equine foamy virus. J Virol (2000) 1.30
A defective human foamy provirus generated by pregenome splicing. EMBO J (1993) 1.29
Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol (1999) 1.29
A second immunologic type of simian foamy virus: monkey throat infections and unmasking by both types. J Infect Dis (1961) 1.29
Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol (1975) 1.28
Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun (1973) 1.26
Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet (1979) 1.23
An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes. J Virol (1999) 1.23
Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am J Pathol (1993) 1.22
Characteization and distribution of two new foamy viruses isolated from chimpanzees. Arch Gesamte Virusforsch (1972) 1.21
Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol (1995) 1.16
Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection. Virology (1998) 1.16
Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol (1998) 1.15
Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol (1996) 1.13
No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses (1996) 1.13
Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol (1979) 1.12
Productive persistent infection of hematopoietic cells by human foamy virus. J Virol (1996) 1.12
Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect Immun (1975) 1.11
Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol (1999) 1.09
Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun (1971) 1.08
Helper-free foamy virus vectors. Hum Gene Ther (1998) 1.07
Isolation of foamy virus from patient with dialysis encephalopathy. Lancet (1978) 1.07
Isolation of a new foamy retrovirus from orangutans. J Virol (1994) 1.06
Long-term persistent infection of domestic rabbits by the human foamy virus. Virology (1997) 1.06
The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J Gen Virol (1980) 1.06
Syncytium-forming agent isolated from domestic cats. Nature (1969) 1.06
Characterization of the internal promoter of simian foamy viruses. J Virol (1994) 1.06
Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses (1998) 1.05
Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology (1996) 1.05
Transduction of hematopoietic cells by foamy virus vectors. Blood (1996) 1.05
Genetic stability of foamy viruses: long-term study in an African green monkey population. J Virol (1999) 1.03
Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene. Virology (1994) 1.02
Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proc Natl Acad Sci U S A (1992) 1.02
Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses. J Infect Dis (1978) 1.01
Mouse model to study the replication of primate foamy viruses. J Gen Virol (1997) 1.00
Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology (1980) 0.99
Human spumavirus antibodies in sera from African patients. Arch Virol (1992) 0.99
Further observations on a human syncytial virus from a nasopharyngeal carcinoma. J Natl Cancer Inst (1974) 0.98
Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol (1992) 0.97
Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol (1992) 0.97
Seroprevalence of Bartonella henselae infection and correlation with disease status in cats in Switzerland. J Clin Microbiol (1997) 0.96
Serologic screening of rhesus and grivet monkeys for SV40 and the foamy viruses. Proc Soc Exp Biol Med (1968) 0.96
In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol (1996) 0.96
Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res (1993) 0.95
Feline viruses in wildcats from Scotland. J Wildl Dis (1999) 0.95
Nonhuman primate spumavirus infections among persons with occupational exposure--United States, 1996. MMWR Morb Mortal Wkly Rep (1997) 0.93
Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res Virol (1994) 0.93
Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J Clin Microbiol (1999) 0.93
The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta (1993) 0.92
Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses (1994) 0.91
Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology (1998) 0.89
Human foamy virus infection in myasthenia gravis. Lancet (1994) 0.89
Antigenic relationship of human foamy virus to the simian foamy viruses. Infect Immun (1978) 0.88
Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int Arch Allergy Immunol (1992) 0.87
A serological survey of bovine syncytial virus in Ontario: associations with bovine leukemia and immunodeficiency-like viruses, production records, and management practices. Can J Vet Res (1995) 0.86
Human foamy virus genome in the thymus of myasthenia gravis patients. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi (1996) 0.86
Biochemical properties of a hamster syncytium-forming ("foamy") virus. J Natl Cancer Inst (1975) 0.86
Isolation of a retrovirus and a herpesvirus from a captive California sea lion. J Wildl Dis (1986) 0.86
Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol (1996) 0.85
Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency. Arch Virol (1982) 0.85
Studies on simian foamy viruses and syncytium-forming viruses of lower animals. Lab Anim Sci (1974) 0.84
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science (1996) 3.25
Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs. J Virol (1993) 2.52
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol (1994) 2.21
Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol (1993) 2.18
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol (1996) 1.91
Evidence that the human foamy virus genome is DNA. J Virol (1999) 1.85
The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol (1998) 1.82
Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J Biol Chem (1996) 1.46
Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol (2001) 1.38
Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence. J Virol (1996) 1.36
A model system for nonhomologous recombination between retroviral and cellular RNA. J Virol (1993) 1.32
Unusual features of integrated cDNAs generated by infection with genome-free retroviruses. Mol Cell Biol (1990) 1.32
Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol (1995) 1.31
Foamy virus infection in primates. J Med Primatol (2006) 1.23
Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol (2006) 1.23
The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology (1995) 1.23
A minimal avian retroviral packaging sequence has a complex structure. J Virol (1998) 1.20
Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles. J Virol (1999) 1.18
Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol (2000) 1.14
Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal. J Virol (2000) 1.12
Productive persistent infection of hematopoietic cells by human foamy virus. J Virol (1996) 1.12
Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b. J Virol (1992) 1.09
An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J Virol (1999) 1.07
Tissue-specific lability and expression of avian leukosis virus long terminal repeat enhancer-binding proteins. Mol Cell Biol (1989) 1.05
Cell-type-specific regulation of the two foamy virus promoters. J Virol (2001) 1.00
The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays. J Virol (1999) 0.99
The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors. J Virol (1995) 0.97
gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3. J Virol (1992) 0.92
Endogenous virus of BHK-21 cells complicates electron microscopy studies of foamy virus maturation. J Virol (1999) 0.89
FH3, a v-myc avian retrovirus with limited transforming ability. J Virol (1989) 0.88
Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression. Oncogene (2001) 0.87
Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection. J Virol (1993) 0.87
Yeast three-hybrid screening of rous sarcoma virus mutants with randomly mutagenized minimal packaging signals reveals regions important for gag interactions. J Virol (2000) 0.86
Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol Cell Biol (1993) 0.85
v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype. Oncogene (1995) 0.77
Tail-to-head arrangement of a partial chicken glyceraldehyde-3-phosphate dehydrogenase processed pseudogene. J Mol Evol (1997) 0.77
Characterization of a unique retroviral recombinant containing 7S L sequences. J Virol (1993) 0.77
Retrotransposition of nonviral RNAs in an avian packaging cell line. J Virol (1998) 0.77
Inhibition of wild-type HIV-1 virus production by a matrix deficient Gag mutant. Virology (1995) 0.75